Gang Wang
Directeur/Membre du Conseil chez SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Guo Dong Jia | M | 43 | 7 ans | |
| Jianjun Zou | M | 52 | 2 ans | |
| Zhuo Bing Zhang | M | 56 | 12 ans | |
| Rui Dong Pan | M | 56 | 11 ans | |
| Feng He | F | 44 |
Hrain Biotechnology Co., Ltd.
 Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | 9 ans |
| Fei Huang | M | 46 |
Hrain Biotechnology Co., Ltd.
Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | 9 ans |
| Shan Yin | F | 42 | 11 ans | |
| Jun Yi Pan | M | 30 | 7 ans | |
| Guo Qing Li | M | 56 |
Hrain Biotechnology Co., Ltd.
Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | 9 ans |
| Lin Sun | M | 51 |
Hrain Biotechnology Co., Ltd.
Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | 3 ans |
| Zhao Rui Song | M | 49 | 3 ans | |
| Fang Xiang | M | 45 |
Hrain Biotechnology Co., Ltd.
Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | 4 ans |
| Xiao Gao | M | 39 | 4 ans | |
| Bei Zhao | M | 66 |
Hrain Biotechnology Co., Ltd.
Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | 3 ans |
| Ying De Qiu | M | 45 |
Hrain Biotechnology Co., Ltd.
Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | 4 ans |
| Fu Jie Wang | M | 49 | 10 ans | |
| Li Ning Gan | M | 46 | 4 ans | |
| Zheng Qi Song | M | 43 | 4 ans | |
| Tao Huang | F | 53 |
Hrain Biotechnology Co., Ltd.
Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | 8 ans |
| Roy Herbst | M | 60 | 6 ans | |
| Sheng Yao | M | 48 | 10 ans | |
| An Ming Meng | M | 60 | 1 ans | |
| Xiao Yuan Feng | M | 67 | 3 ans | |
| Cong Li | M | 60 | 8 ans | |
| Ning Li | M | 63 | 6 ans | |
| Yu Wu | M | 39 | 6 ans | |
| Zhi Qian | M | 56 | 6 ans | |
| Chun Zhang | M | 67 | 4 ans | |
| Hui Feng | M | 48 | 10 ans | |
| Jun Xiong | M | 50 | 9 ans | |
| Lu Yuan Xu | F | 54 | 8 ans | |
| Yang Liu | M | 36 |
Hrain Biotechnology Co., Ltd.
Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | 3 ans |
| Zhi Qing Tang | M | 41 |
Hrain Biotechnology Co., Ltd.
Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | 3 ans |
| Xin Li | M | 45 | 1 ans | |
| Hai Ying Wang | M | 42 |
Hrain Biotechnology Co., Ltd.
Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | 9 ans |
| Dan Hong Wang | F | 58 |
Hrain Biotechnology Co., Ltd.
Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | 7 ans |
| Zhao Jin Zhu | M | 47 |
Hrain Biotechnology Co., Ltd.
Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | 4 ans |
| Si Jie Song | M | 29 | 6 ans | |
| He Ze Zheng | M | 30 |
Hrain Biotechnology Co., Ltd.
Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | 3 ans |
| Guo Shun Li | M | 55 |
Hrain Biotechnology Co., Ltd.
Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | 9 ans |
| Patricia Keegan | M | - | - | |
| Wei Qian | M | - | 3 ans | |
| Yilian Huo | F | 33 | 3 ans | |
| Zheng Yu Wang | M | 29 | 5 ans | |
| Ke Jia Yuan | M | 40 | 4 ans | |
| Bao Hong Xu | M | 45 | 4 ans | |
| Xin Duan | M | 52 | 5 ans | |
| Ping Ping Wang | F | 42 | 6 ans | |
| Siu Kuen Lai | F | 48 | 3 ans | |
| Yi Tang | M | 56 | 9 ans | |
| Wen Zhao | F | - | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Hai Wu | M | 51 | 10 ans | |
| Lie Ping Chen | M | 67 | 5 ans | |
| Ruo Lin Li | F | 32 | 4 ans | |
| Ying Ge Chen | F | 33 | 7 ans | |
| Yuan Yuan Xu | F | 38 | 2 ans | |
| Jia He | M | 70 | 2 ans | |
| Hua Liang Jiang | M | 59 | - | |
| Xin Jun Chen | M | 51 | 2 ans | |
| Nie Anna | F | 32 | 2 ans | |
| Pai Zhu | M | 31 | - | |
| Ce Xiong Fu | M | 47 | 1 ans | |
| Yik Han Wong | F | - | - | |
| Jing Han | M | 51 | 2 ans | |
| Jeffrey D. Storey | M | 58 |
Dartmouth Medical School
| 3 ans |
| Duane Nash | M | 53 |
Dartmouth Medical School
| 4 ans |
| Qing Qing Yi | M | 52 | 5 ans | |
| Jun Liu | M | 45 | 2 ans | |
| Christopher Demuth Sharp | M | - |
Dartmouth Medical School
| 3 ans |
| Christine Brennan | M | 56 |
Dartmouth Medical School
| 5 ans |
| Li Jun Lin | M | 51 | 4 ans | |
| Long Xia | M | 37 | 1 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Chine | 68 | 94,44% |
| Etats-Unis | 4 | 5,56% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
